Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Residual Methylation of Tumor Suppressor Gene Promoters, Rassf6 and Rassf10, As Novel Biomarkers for Minimal Residual Disease Detection in Adult Acute Lymphoblastic Leukemia
Farzad Kompani
Farzad Kompani

Professor of Pediatric Hematology and Oncology

Department Pediatrics

School of Medicine

Childrens Medical Center

Tehran University of Medical Sciences

All Documents
1. Cancer Screening and Its Associated Factors in Hypertensive Individuals: New Insights From the 2021 Steps National Study in Iran, BMC Public Health (2025)
2. Burden of Disease Scenarios for 204 Countries and Territories, 2022–2050: A Forecasting Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
3. Burden of Disease Scenarios for 204 Countries and Territories, 2022–2050: A Forecasting Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
4. Global Age-Sex-Specific Mortality, Life Expectancy, and Population Estimates in 204 Countries and Territories and 811 Subnational Locations, 1950–2021, and the Impact of the Covid-19 Pandemic: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
5. Global Age-Sex-Specific Mortality, Life Expectancy, and Population Estimates in 204 Countries and Territories and 811 Subnational Locations, 1950–2021, and the Impact of the Covid-19 Pandemic: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
6. Global Burden and Strength of Evidence for 88 Risk Factors in 204 Countries and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
7. Global Burden and Strength of Evidence for 88 Risk Factors in 204 Countries and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
8. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
9. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
10. Global Fertility in 204 Countries and Territories, 1950–2021, With Forecasts to 2100: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
11. Global Fertility in 204 Countries and Territories, 1950–2021, With Forecasts to 2100: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
12. Global Incidence, Prevalence, Years Lived With Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (Hale) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
13. Global Incidence, Prevalence, Years Lived With Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (Hale) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
14. Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
15. Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
16. Global, Regional, and National Burden of Injuries, and Burden Attributable to Injuries Risk Factors, 1990 to 2019: Results From the Global Burden of Disease Study 2019, Public Health (2024)
17. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
18. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
19. Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet (2024)
20. Global, Regional, and National Stillbirths at 20 Weeks' Gestation or Longer in 204 Countries and Territories, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet (2024)
21. Global, Regional, and National Survey on Burden and Quality of Care Index (Qci) of Nasopharyngeal Cancer: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Oral Oncology Reports (2024)
22. Immune Thrombocytopenic Purpura (Itp) and Chorioretinopathy in Chronic Granulomatous Disease: A Case Report, Journal of Clinical Immunology (2024)
23. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
24. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
25. Primary Hepatic Neuroblastoma in a 5.5-Month-Old Boy: A Case Report, Archives of Iranian Medicine (2024)
26. Temporal Patterns of Cancer Burden in Asia, 1990–2019: A Systematic Examination for the Global Burden of Disease 2019 Study, The Lancet Regional Health - Southeast Asia (2024)
27. Temporal Patterns of Cancer Burden in Asia, 1990–2019: A Systematic Examination for the Global Burden of Disease 2019 Study, The Lancet Regional Health - Southeast Asia (2024)
28. The Global, Regional, and National Burden and Quality of Care Index of Kidney Cancer; a Global Burden of Disease Systematic Analysis 1990-2019, International Journal for Quality in Health Care (2024)
29. Trends and Levels of the Global, Regional, and National Burden of Appendicitis Between 1990 and 2021: Findings From the Global Burden of Disease Study 2021, The Lancet Gastroenterology and Hepatology (2024)
30. Trends and Levels of the Global, Regional, and National Burden of Appendicitis Between 1990 and 2021: Findings From the Global Burden of Disease Study 2021, The Lancet Gastroenterology and Hepatology (2024)
31. Unveiling the Lead Exposure Attributed Burden in Iran From 1990 to 2019 Through the Lens of the Global Burden of Disease Study 2019, Scientific Reports (2024)
32. A Year of Experience With Covid-19 in Patients With Cancer: A Nationwide Study, Cancer Reports (2023)
33. Burden of Tracheal, Bronchus, and Lung Cancer in North Africa and Middle East Countries, 1990 to 2019: Results From the Gbd Study 2019, Frontiers in Oncology (2023)
34. Burden of Tracheal, Bronchus, and Lung Cancer in North Africa and Middle East Countries, 1990 to 2019: Results From the Gbd Study 2019, Frontiers in Oncology (2023)
35. Current Status and Future Perspectives of Wilms Tumor Treatment in Iran, Annals of Medicine and Surgery (2023)
36. Epidemiology of Brain and Other Central Nervous System Cancers in the North Africa and Middle East Region: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, World Neurosurgery (2023)
37. Expression of Long Non-Coding Rna H19 in Acute Lymphoblastic Leukemia, Cell Journal (2023)
38. Global Burden of Cardiovascular Diseases and Risks, 1990-2022, Journal of the American College of Cardiology (2023)
39. Global Burden of Chronic Respiratory Diseases and Risk Factors, 1990–2019: An Update From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
40. Global Burden of Chronic Respiratory Diseases and Risk Factors, 1990–2019: An Update From the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
41. Global Investments in Pandemic Preparedness and Covid-19: Development Assistance and Domestic Spending on Health Between 1990 and 2026, The Lancet Global Health (2023)
42. Global Investments in Pandemic Preparedness and Covid-19: Development Assistance and Domestic Spending on Health Between 1990 and 2026, The Lancet Global Health (2023)
43. Global, Regional, and National Burden of Allergic Disorders and Their Risk Factors in 204 Countries and Territories, From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Allergy: European Journal of Allergy and Clinical Immunology (2023)
44. Global, Regional, and National Burden of Allergic Disorders and Their Risk Factors in 204 Countries and Territories, From 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Allergy: European Journal of Allergy and Clinical Immunology (2023)
45. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
46. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
47. Global, Regional, and National Burden of Meningitis and Its Aetiologies, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2023)
48. Global, Regional, and National Burden of Meningitis and Its Aetiologies, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2023)
49. Global, Regional, and National Burden of Rheumatoid Arthritis, 1990–2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2023)
50. Global, Regional, and National Prevalence and Mortality Burden of Sickle Cell Disease, 2000–2021: A Systematic Analysis From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)
51. Global, Regional, and National Prevalence and Mortality Burden of Sickle Cell Disease, 2000–2021: A Systematic Analysis From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)
52. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
53. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
54. Minimal Residual Disease Detection Using Gene Scanning Analysis, Fluorescent Fragment Analysis, and Capillary Electrophoresis for Igh Rearrangement in Adult B-Lineage Acute Lymphoblastic Leukemia: A Cross-Sectional Study, Cell Journal (2023)
55. National and Subnational Burden of Brain and Central Nervous System Cancers in Iran, 1990–2019: Results From the Global Burden of Disease Study 2019, Cancer Medicine (2023)
56. National and Subnational Burden of Leukemia and Its Risk Factors, 1990-2019: Results From the Global Burden of Disease Study 2019, PLoS ONE (2023)
57. Prevalence, Years Lived With Disability, and Trends in Anaemia Burden by Severity and Cause, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)
58. Prevalence, Years Lived With Disability, and Trends in Anaemia Burden by Severity and Cause, 1990–2021: Findings From the Global Burden of Disease Study 2021, The Lancet Haematology (2023)
59. Regional and National Burden of Leukemia and Its Attributable Burden to Risk Factors in 21 Countries and Territories of North Africa and Middle East, 1990–2019: Results From the Gbd Study 2019, Journal of Cancer Research and Clinical Oncology (2023)
60. The Burden of Childhood and Adolescent Cancers in North Africa and the Middle East (Name) Region: Findings From the Global Burden of Disease Study 2019, BMC Pediatrics (2023)
61. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2023)
62. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2023)
63. Trends of National and Sub-National Burden Attributed to Kidney Dysfunction Risk Factor in Iran: 1990-2019, Frontiers in Endocrinology (2023)
64. Trends of National and Sub-National Burden Attributed to Kidney Dysfunction Risk Factor in Iran: 1990-2019, Frontiers in Endocrinology (2023)
65. Women Participation in Health Research of Iran: Analysis of Challenges and Strategies With Literature of Review, Iranian Journal of Public Health (2023)
66. Adolescent Transport and Unintentional Injuries: A Systematic Analysis Using the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
67. Adolescent Transport and Unintentional Injuries: A Systematic Analysis Using the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
68. Age–Sex Differences in the Global Burden of Lower Respiratory Infections and Risk Factors, 1990–2019: Results From the Global Burden of Disease Study 2019, The Lancet Infectious Diseases (2022)
69. Age–Sex Differences in the Global Burden of Lower Respiratory Infections and Risk Factors, 1990–2019: Results From the Global Burden of Disease Study 2019, The Lancet Infectious Diseases (2022)
70. Estimating the Burden of Diseases Attributable to Lead Exposure in the North Africa and Middle East Region, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Environmental Health: A Global Access Science Source (2022)
71. Global Mortality Associated With 33 Bacterial Pathogens in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
72. Global Mortality Associated With 33 Bacterial Pathogens in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
73. Global, Regional, and National Burden and Quality of Care Index in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 1990–2017, PLoS ONE (2022)
74. Hematological Indices in Pediatric Patients With Acyanotic Congenital Heart Disease: A Cross-Sectional Study of 248 Patients, Egyptian Journal of Medical Human Genetics (2022)
75. Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type-1 Diabetes Patients: A Phase I/Ii Randomized Placebo-Controlled Clinical Trial, Stem Cell Research and Therapy (2022)
76. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
77. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
78. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
79. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
80. A Global, Regional, and National Survey on Burden and Quality of Care Index (Qci) of Brain and Other Central Nervous System Cancers; Global Burden of Disease Systematic Analysis 1990-2017, PLoS ONE (2021)
81. A Global, Regional, and National Survey on Burden and Quality of Care Index (Qci) of Hematologic Malignancies; Global Burden of Disease Systematic Analysis 1990–2017, Experimental Hematology and Oncology (2021)
82. A Nationwide Study of Metabolic Syndrome Prevalence in Iran; a Comparative Analysis of Six Definitions, PLoS ONE (2021)
83. Global, Regional, and National Survey on the Burden and Quality of Care of Pancreatic Cancer: A Systematic Analysis for the Global Burden of Disease Study 1990–2017, Pancreatology (2021)
84. Hepatocellular Carcinoma Incidence at National and Provincial Levels in Iran From 2000 to 2016: A Meta-Regression Analysis, PLoS ONE (2021)
85. National and Provincial Population-Based Incidence and Mortality of Skin Cancer in Iran; 1990–2016, Asia-Pacific Journal of Clinical Oncology (2021)
86. Post-Chemotherapy Foamy Histiocytes in Bone Marrow Aspiration of a Child With Acute Lymphoblastic Leukemia; [Akut Lenfoblastik Losemili Bir Cocugun Kemik Iligi Aspirasyonunda Kemoterapi Sonrasi Kopuklu Histiyositler], Turkish Journal of Hematology (2021)
87. National and Subnational Trends in Incidence and Mortality of Lung Cancer in Iran From 1990 to 2016, Asia-Pacific Journal of Clinical Oncology (2020)
88. Requirements of Mental Health Services During the Covid-19 Outbreak: A Systematic Review, Iranian Journal of Psychiatry and Clinical Psychology (2020)
89. Study of T-Cell Immunoglobulin and Mucin Domain-3 Expression Profile in Peripheral Blood and Bone Marrow of Human Acute Lymphoblastic Leukemia Patients, Journal of Research in Medical Sciences (2020)
90. Study of T-Cell Immunoglobulin and Mucin Domain-3 Expression Profile in Peripheral Blood and Bone Marrow of Human Acute Lymphoblastic Leukemia Patients, Journal of Research in Medical Sciences (2020)
91. Trends of National and Subnational Incidence of Childhood Cancer Groups in Iran: 1990–2016, Frontiers in Oncology (2020)
92. National and Sub-National Pediatric Cancer Mortality in Iran, 2000-2015, Archives of Iranian Medicine (2019)
93. National and Subnational Mortality of Urological Cancers in Iran, 1990–2015, Asia-Pacific Journal of Clinical Oncology (2019)
94. Serum Ferritin Levels and Irregular Use of Iron Chelators Predict Liver Iron Load in Patients With Major Beta Thalassemia: A Cross-Sectional Study, Croatian Medical Journal (2019)
95. Annual Trends of Gastrointestinal Cancers Mortality in Iran During 1990-2015; Nasbod Study, Archives of Iranian Medicine (2018)
96. Anthracycline-Induced Cardiothoxicity in Children Cancer Patients: An Imaging Study by Two-Dimensional Global Longitudinal Strain Using Automated Function Imaging Technique, Journal of Comprehensive Pediatrics (2018)
97. Death-Specific Rate Due to Asthma and Chronic Obstructive Pulmonary Disease in Iran, Clinical Respiratory Journal (2018)
98. In Vitro Study of Hax1 Gene Therapy by Retro Viral Transduction As a Therapeutic Target in Severe Congenital Neutropenia, European Cytokine Network (2018)
99. The Prevalence, Awareness, and Treatment of Lipid Abnormalities in Iranian Adults: Surveillance of Risk Factors of Noncommunicable Diseases in Iran 2016, Journal of Clinical Lipidology (2018)
100. A 9-Year Old Boy With Leukemia and Oral Manifestation: A Case Report and Review of Literature, Galen Medical Journal (2016)
101. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: Report of Three Cases From Iran, Journal of Pediatric Endocrinology and Metabolism (2016)
102. Burden of Malaria in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2016)
103. Burden of Vaccine-Preventable Diseases—Measles, Tetanus, Diphtheria and Whooping Cough—In Iran: Findings From the Gbd Study 2010, Archives of Iranian Medicine (2016)
104. Changes of Platelet Indices in Juvenile Idiopathic Arthritis in Acute Phase and After Two Months Treatment, Iranian Journal of Pediatrics (2016)
105. Fournier’S Gangrene in a Neonate With Acute Myeloid Leukemia: A Case Report, Iranian Journal of Pediatrics (2016)
106. The Burden of Hiv in Iran: Insights From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2016)
107. Burden of Cancers in Iran From 1990 to 2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
108. Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6pd Deficiency) in Iran, 1990–2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)